课题基金 / 基金详情

Regulation of eEF-2K an Energy and Nutrient Sensor

Regulation of eEF-2K an Energy and Nutrient Sensor
能量和营养传感器 eEF-2K 的调节
批准号:
10658322
负责人:
Kevin N Dalby
金额:
$42.75万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-15 至 2025-08-31

项目摘要

项目成果

Kevin N Dalby的其他基金

相关文献

中文摘要
翻译
有一个迫切需要破译翻译伸长失调的作用在各种慢性神经系统疾病和许多癌症。推动拟议研究的长期目标是帮助制定针对eEF2K的治疗策略,以治疗进行性神经退行性疾病和恶性肿瘤。本申请的总体目标是:(i)表征eEF2K活化和调控的动力学机制;(ii)阐明二价阳离子、pH、ADP和eEF2K调控的结构基础
英文摘要
There is a compelling need to decipher the role of the dysregulation of translation elongation in various chronic neurological conditions and many cancers. The long-term goal driving the proposed research is to help develop therapeutic strategies targeting eEF2K for treating progressive neurodegenerative diseases and malignancies. The overall objectives of this application are to (i) characterize the kinetic mechanism of eEF2K activation and regulation and (ii) elucidate the structural basis for the regulation of eEF2K by divalent cations, pH, ADP, and specific post-translational modifications. The central hypothesis is that calmodulin (CaM) binding activates eEF2K by profoundly altering its conformational dynamics, leading to a state capable of efficient phosphoryl transfer. Multiple regulatory inputs control the attainment of this state. The rationale is that understanding the mechanism of eEF2K regulation is necessary to provide a robust scientific framework for developing novel therapeutic approaches targeting neurodegenerative diseases and cancer. The central hypothesis will be tested through two specific aims: (1) to define the kinetic mechanism of activation of eEF2K by calmodulin and the kinetic basis for the modulation of its activity, (2) to determine the structural and dynamic basis of how specific inputs and post-translational modifications regulate the stability of active states of eEF2K. In the first aim, presteady state kinetics will define the precise allosteric mechanism of eEF2K activation and modulation of its activity. The second aim will determine the modulatory effects of specific post-translational modifications and other regulatory inputs in affecting the CaM sensitivity of the active state using a variety of structural approaches. The findings from both aims will be validated by characterizing eEF2K activation and activity in mammalian cells. In our opinion, the research proposed in this application is innovative because it focuses on understanding the relationships between the structural dynamics and the temporal control of eEF2K in mammalian cells using a unique combination of techniques integrated over multiple length scales from the atomic to the cellular. The proposed research is significant because it is expected to provide new insight into the cellular regulation of protein translation by eEF2K and provide critical advancement in understanding various eEF2K-driven pathologies.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1073/pnas.2300902120
发表时间: 2023-04-25
期刊: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子: 11.1
作者: [Piserchio, Andrea, Long, Kimberly J., Browning, Luke S., Bohanon, Amanda L., Isiorho, Eta A., Dalby, Kevin N., Ghose, Ranajeet]
通讯作者: Ghose, Ranajeet
DOI: 10.1016/j.jbc.2023.104813
发表时间: 2023-06
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Piserchio, Andrea, Isiorho, Eta A, Dalby, Kevin N, Ghose, Ranajeet]
通讯作者: Ghose, Ranajeet
Quantification of ERK Kinase Activity in Biological Samples Using Differential Sensing.
使用差分传感定量生物样品中的 ERK 激酶活性。
DOI: 10.1021/acschembio.9b00580
发表时间: 2020
期刊: ACS chemical biology
影响因子: 4
作者: [Zamora-Olivares,Diana, Kaoud,TamerS, Zeng,Lingyu, Pridgen,JaceyR, Zhuang,DeborahL, Ekpo,YakndaraE, Nye,JessicaR, Telles,Mitchell, Anslyn,EricV, Dalby,KevinN]
通讯作者: Dalby,KevinN
Raf protomers: Drug binding preferences in living cells.
Raf 原体:活细胞中的药物结合偏好。
DOI: 10.1016/j.chembiol.2023.10.002
发表时间: 2023
期刊: Cell chemical biology
影响因子: 8.6
作者: [Dalby,KevinN]
通讯作者: Dalby,KevinN
9
    Dual-Mechanism Allosteric Inhibitors of ERK Signaling
    • 批准号:
      10446852
    • 项目类别:
    • 资助金额:
      $53.78万
    • 财政年份:
      2022
    • 负责人:
      Kevin N Dalby
    • 依托单位:
    Dual-Mechanism Allosteric Inhibitors of ERK Signaling
    • 批准号:
      10614057
    • 项目类别:
    • 资助金额:
      $52.74万
    • 财政年份:
      2022
    • 负责人:
      Kevin N Dalby
    • 依托单位:
    Mechanism of Activation of eEF-2K, an Energy and Nutrient Sensor
    • 批准号:
      9289618
    • 项目类别:
    • 资助金额:
      $41.57万
    • 财政年份:
      2017
    • 负责人:
      Kevin N Dalby
    • 依托单位:
    Novel Therapeutics for Translation Control in Breast Cancer
    • 批准号:
      8528524
    • 项目类别:
    • 资助金额:
      $15.61万
    • 财政年份:
      2012
    • 负责人:
      Kevin N Dalby
    • 依托单位: